Results 21 to 30 of about 883,314 (350)
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in patients with cardiogenic shock, although the evidence supporting its use in this context remains insufficient.
P. Ostadal+15 more
semanticscholar +1 more source
Background: Cardiogenic shock is a serious complication of a ST-segment elevation myocardial infarction (STEMI). We compared short- and long-term mortality among (1) STEMI patients with and without cardiogenic shock and (2) STEMI patients with ...
Jesper Khedri Jensen+6 more
doaj +1 more source
The use of temporary mechanical circulatory support in cardiogenic shock has increased dramatically despite a lack of randomized controlled trials or evidence guiding clinical decision-making.
Bram J Geller+12 more
semanticscholar +1 more source
Stroke following percutaneous coronary intervention : type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12 [PDF]
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015.
Berry, Colin+11 more
core +1 more source
Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Cardiogenic shock is one of the main causes of death in patients with acute myocardial infarction with the mortality rates being as high as 60—80%. Extracorporeal membrane oxygenation (ECMO) is a life-saving technique in patients with cardiogenic shock ...
I. A. Kornilov+5 more
doaj +1 more source
Background Venoarterial extracorporeal membrane oxygenation (va-ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock.
Sasa Rajsic+6 more
semanticscholar +1 more source
Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio+8 more
core +1 more source
Diagnosis and Management of COVID-19 Disease [PDF]
SARS-CoV-2 is a novel coronavirus that was identified in late 2019 as the causative agent of COVID-19 (aka coronavirus disease 2019). On March 11, 2020, the World Health Organization (WHO) declared the world-wide outbreak of COVID-19 a pandemic.
Carlos, Graham+5 more
core +1 more source
Myocardial localization of coronavirus in COVID‐19 cardiogenic shock
We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in a 69‐year‐old patient with flu‐like symptoms rapidly degenerating into respiratory distress ...
G. Tavazzi+15 more
semanticscholar +1 more source
Cardiogenic Shock After Acute Myocardial Infarction: A Review.
Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per year and is the leading cause of in-hospital mortality following acute myocardial infarction.
Marc D. Samsky+5 more
semanticscholar +1 more source